Otolaryngology Doctors in Salem, MA Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Charles J. Leidner, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 55 Highland Avuene, Suite 201, Salem, MA 01970 Phone: 978-745-6601    Fax: 978-744-4872

Terry J Garfinkle, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 55 Highland Avenue, Suite 201, Salem, MA 01970 Phone: 978-745-6601    Fax: 978-744-4872

John G Hernandez, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 79 Highland Ave, Suite 308, Salem, MA 01970 Phone: 978-745-0151    Fax: 978-745-0203

Jeannie Hye-joon Chung, MD Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Not Enrolled in Medicare Practice Location: 107 Highland Ave, Salem, MA 01970 Phone: 978-744-3223    Fax: 978-744-4990

News Archive

FDA grants marketing clearance to Accuray's CyberKnife VSI System Lung Optimized Treatment

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market Lung Optimized Treatment, a new component of the CyberKnife® VSI™ System. The 510(k) clearance enables Accuray to provide physicians with greater flexibility in delivering radiosurgery treatments to patients with lung cancer, the most common and deadly cancer worldwide.

University of Iowa receives a $26.4M gift commitment from the Pappajohns

University of Iowa President Sally Mason announced today a $26.4 million gift commitment from longtime UI benefactors John and Mary Pappajohn of Des Moines - the largest single gift commitment ever for the UI from individual Iowa donors - and said it will provide the university's new interdisciplinary Institute for Biomedical Discovery with "the catalyst it needs to reach its full potential."

Biosystems International closes EUR2.1 million funding round

Biosystems International (BSI) SAS, Biotech Leader in the Development of Monoclonal Antibody Based Diagnostics for Cancer, Announced Today That it has Closed a Round of Funding Amounting to EUR2.1 Million ($2.7 Million).

FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose

The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products.

Study identifies clearest link yet to obesity risk

Scientists have identified the most clear genetic link yet to obesity in the general population as part of a major study of diseases funded by the Wellcome Trust, the UK's largest medical research charity.

Read more Medical News

› Verified 4 days ago